Niadyne Overview
- Year Founded
-
1997

- Status
-
Private
- Latest Deal Type
-
Debt
- Financing Rounds
-
3
Niadyne General Information
Description
Developer of various skin care products for the treatment and prevention of sun damage to skin. The company offers day therapy, night treatment, facial cleanser and facial scrub skin care products through physicians and other products for scalp and hair follicle function, and optimization of cholesterol and other blood lipids.
Contact Information
Website
www.nia24.comCorporate Office
- 285 Madison Avenue
- Suite 1200
- New York, NY 10017
- United States
Corporate Office
- 285 Madison Avenue
- Suite 1200
- New York, NY 10017
- United States
Niadyne Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Niadyne Comparisons
Industry
Financing
Details
Niadyne Competitors (1)
One of Niadyne’s competitors is StriVectin Operating Company, a Private Equity-Backed company based in New York, NY.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
StriVectin Operating Company | Private Equity-Backed | New York, NY |
Niadyne Patents
Niadyne Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20090318508-A1 | Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore | Active | 24-Jun-2005 | ||
US-8114390-B2 | Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore | Inactive | 24-Jun-2005 | ||
US-20120093739-A1 | Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore | Active | 24-Jun-2005 | ||
US-8790626-B2 | Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore | Active | 24-Jun-2005 | ||
US-7217739-B2 | D-penicillamine, amino guanidine, or 3 methyl-3 ethyl cysteine(mec); to induce or to accelerate death of said abnormal cell; abnormal cell is a melanoma, a squamous carcinoma cell, an adenocarcinoma cell, an epithelial carcinoma cell, or a premalignant keratinocyte | Active | 02-Mar-2004 | A61K31/155 |
Niadyne FAQs
-
When was Niadyne founded?
Niadyne was founded in 1997.
-
Where is Niadyne headquartered?
Niadyne is headquartered in New York, NY.
-
What industry is Niadyne in?
Niadyne’s primary industry is Personal Products.
-
Is Niadyne a private or public company?
Niadyne is a Private company.
-
What is Niadyne’s current revenue?
The current revenue for Niadyne is
. -
Who are Niadyne’s competitors?
StriVectin Operating Company is a competitor of Niadyne.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »